Fundraising FoxConsortiEX
Andover, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into ConsortiEX
Sign up to see every warm intro you have to ConsortiEX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ConsortiEX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ConsortiEX provides healthcare information technology solutions for pharmacy operations and medication management in hospital systems and health networks. The company serves health systems, pharmacies, and related healthcare facilities with software focused on compliance, safety, and operational efficiency.
Founders & leadership
ConsortiEX was founded in 2013 by Neal Long.
Board
Investors · 1
How we know: Serra Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 3 rounds · 2014–2016
▶$2.6MraisedSep 2016 · 19 investors · Other Health CareRule 506(b)
- Kevin LindseyDirector
- Neal K. LongExecutive Officer, Director
- Richard GriffinDirector
- Offering amount
- $3.1M
- Amount sold
- $2.6M
- Proceeds to insiders
- $175K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$625KraisedJan 2016 · 15 investors · Other Health CareRule 506(b)
- Lyle HohnkeDirector
- Kevin LindseyDirector
- Neal K. LongExecutive Officer, Director
- Richard GriffinDirector
- Offering amount
- $750K
- Amount sold
- $625K
- Proceeds to insiders
- $50K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$110KraisedSep 2014 · 1 investors · Other Health CareRule 506(b)
- Neal K. LongExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $110K
- Minimum investment
- $110K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as ConsortiEX.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2017 | $750K |
| National Science Foundation | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ConsortiEX do?
- ConsortiEX provides healthcare information technology solutions for pharmacy operations and medication management in hospital systems and health networks. The company serves health systems, pharmacies, and related healthcare facilities with software focused on compliance, safety, and operational efficiency.
- Who founded ConsortiEX?
- ConsortiEX was founded by Neal Long in 2013.
- Who are ConsortiEX's investors?
- ConsortiEX's investors include Serra Ventures.
- How much funding has ConsortiEX raised?
- ConsortiEX has disclosed $3.3M raised across 3 rounds.
- Where is ConsortiEX headquartered?
- ConsortiEX is headquartered in Andover, US.